Kui Guo

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Replacement Therapy

Endometrial Cancer

Estrogen Receptor

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Tianyi Zhao, Hong Yan, Kui Guo, Zhiming Liu, Lina Wei, Wei Lu, Chunping Qiu, Jie Jiang
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell death & disease 12 (6) (2021)